Income Tax Expense (Benefit) in USD of AVADEL PHARMACEUTICALS PLC from 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
AVADEL PHARMACEUTICALS PLC quarterly/annual Income Tax Expense (Benefit) history and change rate from 2010 to Q3 2025.
  • AVADEL PHARMACEUTICALS PLC Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $34K, a 61.4% decline year-over-year.
  • AVADEL PHARMACEUTICALS PLC Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was -$2.98M, a 596% decline year-over-year.
  • AVADEL PHARMACEUTICALS PLC annual Income Tax Expense (Benefit) for 2024 was -$247K, a 50.7% increase from 2023.
  • AVADEL PHARMACEUTICALS PLC annual Income Tax Expense (Benefit) for 2023 was -$501K, a 102% decline from 2022.
  • AVADEL PHARMACEUTICALS PLC annual Income Tax Expense (Benefit) for 2022 was $26M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

AVADEL PHARMACEUTICALS PLC Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$2.98M $34K -$54K -61.4% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 -$2.92M -$3.17M -$2.66M -523% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 -$262K $78K -$15K -16.1% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025
Q4 2024 -$247K $81K +$181K 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2025
Q3 2024 -$428K $88K -$1K -1.12% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025
Q2 2024 -$427K -$509K -$599K -666% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 $172K $93K +$673K 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025
Q4 2023 -$501K -$100K -$185K -218% 01 Oct 2023 31 Dec 2023 10-K 03 Mar 2025
Q3 2023 -$316K $89K +$19K +27.1% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$335K $90K -$30.1M -99.7% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $29.8M -$580K +$3.74M +86.6% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024
Q4 2022 $26M $85K +$4.43M 01 Oct 2022 31 Dec 2022 10-K 03 Mar 2025
Q3 2022 $21.6M $70K +$5.17M 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023
Q2 2022 $16.4M $30.2M +$34M 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 -$17.5M -$4.32M -$1.72M -65.8% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 -$15.8M -$4.34M -$1.49M -52.3% 01 Oct 2021 31 Dec 2021 10-K 29 Feb 2024
Q3 2021 -$14.3M -$5.1M -$61K -1.21% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 -$14.3M -$3.77M -$9.06M -171% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 -$5.21M -$2.61M +$6.9M +72.6% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 -$12.1M -$2.85M +$6.15M +68.3% 01 Oct 2020 31 Dec 2020 10-K 16 Mar 2022
Q3 2020 -$18.3M -$5.04M -$7.27M -326% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021
Q2 2020 -$11M $5.29M +$3.51M +197% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021
Q1 2020 -$14.5M -$9.51M -$9.14M -2443% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021
Q4 2019 -$5.36M -$9M +$5.54M +38.1% 01 Oct 2019 31 Dec 2019 10-K 16 Mar 2022
Q3 2019 -$10.9M $2.23M +$2.93M 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 -$13.8M $1.78M +$2.12M 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 -$15.9M -$374K +$1.95M +83.9% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 -$17.9M -$14.5M -$17.1M -668% 01 Oct 2018 31 Dec 2018 10-K 09 Mar 2021
Q3 2018 -$801K -$691K -$6.61M -112% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 $5.81M -$342K -$7.71M -105% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 $13.5M -$2.33M -$10.9M -127% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019
Q4 2017 $24.4M $2.56M -$10.8M -80.8% 01 Oct 2017 31 Dec 2017 10-K 16 Mar 2020
Q3 2017 $35.2M $5.92M +$2.47M +71.6% 01 Jul 2017 30 Sep 2017 10-Q 05 Nov 2018
Q2 2017 $32.7M $7.37M -$79K -1.06% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018
Q1 2017 $32.8M $8.54M +$1.23M +16.8% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018
Q4 2016 $31.6M $13.3M +$3.72M +38.7% 01 Oct 2016 31 Dec 2016 10-K 15 Mar 2019
Q3 2016 $27.8M $3.45M -$3.85M -52.7% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q2 2016 $31.7M $7.45M -$1.06M -12.4% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017
Q1 2016 $32.7M $7.31M -$3.16M -30.2% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017
Q4 2015 $35.9M $9.63M +$7.58M +370% 01 Oct 2015 31 Dec 2015 10-K 16 Mar 2018
Q3 2015 $28.3M $7.3M +$7.33M 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 $21M $8.51M +$8.37M +6109% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016
Q1 2015 $12.6M $10.5M +$13.3M 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016
Q4 2014 -$644K $2.05M +$6.9M 01 Oct 2014 31 Dec 2014 10-K 28 Mar 2017
Q3 2014 -$7.54M -$29K +$1.2M +97.6% 01 Jul 2014 30 Sep 2014 6-K 17 Nov 2014
Q2 2014 -$8.74M $137K +$3.85M 01 Apr 2014 30 Jun 2014 6-K 31 Dec 2015
Q1 2014 -$12.6M -$2.8M -$1.34M -91.7% 01 Jan 2014 31 Mar 2014 6-K 10 Jul 2015
Q4 2013 -$11.2M -$4.85M -$122K -2.58% 01 Oct 2013 31 Dec 2013 10-K 15 Mar 2016
Q3 2013 -$11.1M -$1.23M -$1.18M -2458% 01 Jul 2013 30 Sep 2013 6-K 17 Nov 2014
Q2 2013 -$9.94M -$3.71M -$3.71M 01 Apr 2013 30 Jun 2013 6-K 08 Aug 2014
Q1 2013 -$6.23M -$1.46M -$1.5M -3581% 01 Jan 2013 31 Mar 2013 6-K 08 Jul 2014
Q4 2012 -$4.73M -$4.72M 01 Oct 2012 31 Dec 2012 20-F 01 Oct 2015
Q3 2012 -$48K 01 Jul 2012 30 Sep 2012 6-K 15 Jan 2014
Q2 2012 $1K* -$62K 01 Apr 2012 30 Jun 2012 6-K 06 Dec 2013
Q1 2012 $42K +$19K +82.6% 01 Jan 2012 31 Mar 2012 6-K 13 Sep 2012
Q2 2011 $63K 01 Apr 2011 30 Jun 2011 6-K 14 Dec 2012
Q1 2011 $23K 01 Jan 2011 31 Mar 2011 6-K 13 Sep 2012

AVADEL PHARMACEUTICALS PLC Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$247K +$254K +50.7% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025
2023 -$501K -$26.5M -102% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025
2022 $26M +$41.8M 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025
2021 -$15.8M -$3.71M -30.6% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024
2020 -$12.1M -$6.75M -126% 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2022
2019 -$5.36M +$12.5M +70.1% 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2022
2018 -$17.9M -$42.3M -173% 01 Jan 2018 31 Dec 2018 10-K 09 Mar 2021
2017 $24.4M -$7.17M -22.7% 01 Jan 2017 31 Dec 2017 10-K 16 Mar 2020
2016 $31.6M -$4.35M -12.1% 01 Jan 2016 31 Dec 2016 10-K 15 Mar 2019
2015 $35.9M +$36.6M 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2018
2014 -$644K +$10.6M +94.3% 01 Jan 2014 31 Dec 2014 10-K 28 Mar 2017
2013 -$11.2M -$6.52M -138% 01 Jan 2013 31 Dec 2013 10-K 15 Mar 2016
2012 -$4.73M -$4.92M -2563% 01 Jan 2012 31 Dec 2012 20-F 01 Oct 2015
2011 $192K -$17K -8.13% 01 Jan 2011 31 Dec 2011 20-F/A 30 Apr 2014
2010 $209K 01 Jan 2010 31 Dec 2010 20-F 30 Apr 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.